FindTrial
Sign In

Immunoglobulin therapy and intestinal blood flows in neonates

Superior mesenteric artery and celiac artery blood flow changes in neonates following immunoglobulin therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/08/001955
Enrollment
20
Registered
2011-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- neonates who have Rh isoimmunization and alloimmune thrombocytopenia

Interventions

Intervention1: Immunoglobulin: Superior and celiac artery doppler velocities prior to and after giving immunoglobulin

Sponsors

Praveen Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonate receiving intravenous immunoglobulin, irrespective of their gestation and birth weight

Exclusion criteria

Exclusion criteria: ? Neonates with established NEC or surgical abdomen like malrotation prior to starting IVIg ? Neonates developing complications of immunoglobulin therapy like hypotension or anaphylaxis

Design outcomes

Primary

MeasureTime frame
Change in Superior mesenteric artery and Celiac artery Doppler indices after immunoglobulin therapyTimepoint: Baseline and after giving immunoglobulin therapy—

Secondary

MeasureTime frame
Incidence of NEC and feed intoleranceTimepoint: with in 5 days of the infusion—

Countries

India

Contacts

Public Contactdeepak louis

PGIMER

lewisfinch2008@yahoo.com9914208374

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026